CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized, Open, Blank Control Study on the Efficacy and Safety of Recombinant Human Interferon α1β in the Treatment of Patients With New Type of Coronavirus Infection in Wuhan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04293887
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:48.223171+00:00
Published At: 2020-03-03T00:00:00+00:00
Record Updated At: 2020-03-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["COVID-19", "Recombinant Human Interferon \u03b11\u03b2"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-03-03"
protocolSection.identificationModule.nctId: "NCT04293887"
protocolSection.identificationModule.officialTitle: "Randomized, Open, Blank Control Study on the Efficacy and Safety of Recombinant Human Interferon \u03b11\u03b2 in the Treatment of Patients With New Type of Coronavirus Infection in Wuhan"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.